Rasagiline Mesylate Tablets.

Effects and efficacy:
Rasagiline mesylate is mainly used for monotherapy of patients with primary Parkinson’s disease and combination therapy (combined with levodopa) in patients with end-of-dose fluctuations.
Usage and dosage:
Oral administration. 1 mg once a day. Taking this product is not affected by food.
Drug contraindications:
Allergy to this product is prohibited. Liver function damage is prohibited. Children should use it with caution. Use with caution during lactation and pregnancy.
Related dosage forms:
Tablets